Navigation Links
Amicus Therapeutics Announces First Quarter 2008 Financial Results
Date:5/13/2008

/p>

Stock GAAP as

Non-GAAP Compensation Reported

Income Statement

Classifications:

Revenue $3,160 $3,160

Research and development (6,412) $(529) (6,941)

General and administrative (4,368) (818) (5,186)

Depreciation and

amortization (321) (321)

Interest income 1,702 1,702

Interest expense (70) (70)

(Provision for)/benefit

from income taxes (75) (75)

Summary:

Net loss: $(6,384) $ (1,347) $ (7,731)

Net loss per share - basic

and diluted: $(0.28) $(0.06) $(0.34)

Weighted average number

of shares outstanding: 22,412,689 22,412,689

Table 3

Amicus Therapeutics, Inc.

Reconciliation of GAAP to non-GAAP Measures for the Statement of Operations Information for Three Months Ended March 31, 2007

(Unaudited)

(In thousands, except share and per share amounts)

Change

in Fair Pre-

Value of ferred

Warrant Stock Stock

Non- Lia- Accre- Compen- GAAP as

GAAP bility tion sation Reported

Income Statement

Classifications:

Research and

development $(6,795) $- $- $(290
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... InferMed , s ... will augment Elsevier ... olutions suite   Elsevier , a world-leading ... announced today the acquisition of  InferMed , a ... InferMed,s Arezzo technology supports clinicians in choosing the most ...
(Date:7/1/2015)... NEW YORK , July 1, 2015 /PRNewswire/ ... G ), a global leader in designing, ... the Aecus Innovation Award in recognition of their ... operational efficiencies in UCB,s global business services (GBS) ... acknowledge service providers and clients that work together ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix ... of common shares of Resverlogix have approved the ... Eastern Capital Limited of 5,600,000 units at a ... Placement"), each unit being comprised of one common ... aggregate proceeds of approximately CAD$15 million; and (ii) ...
(Date:6/30/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ), a ... address unmet medical needs in women,s health, today ... present at the Cantor Fitzgerald Inaugural Healthcare Conference ... 4:45 PM EDTLocation: , Le Parker Meridien Hotel, ... www.juniperpharma.com, under  ,Investor, or  click here ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... Technologies,Inc. (OTC Bulletin Board: BNET) announced that notification was ... Waste,Bioconversion System" has been granted by the Commonwealth of ... 2002227224. The,official filing date is approved as November 8, ... expiration date of November 8, 2021., This patent ...
... ... FUNCTIONAL FOOD market-- LAVAL, QC, Sept. 25 /PRNewswire-FirstCall/ - ... it entered a worldwide alliance with Marine Life Sciences who ... distribution,of dietary supplements and functional food products in the global,nutraceutical ...
... 25 Osteotech, Inc.,(Nasdaq: OSTE ), a leader ... announced today the appointment of Cato T.,Laurencin, M.D., Ph.D. ... of Directors effective September 24, 2008 and will serve ... Board of Directors., Kenneth P. Fallon, III, Chairman ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 3Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 4Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
(Date:6/17/2015)... HILDEN, Germany , June 17, 2015 /PRNewswire/ ... Prime Standard: QIA) today launched new Investigator ® STR ... in the United States . The new ... multiple key genomic markers (short tandem repeats or STRs) for ... to evaluate the quality of DNA in each sample, a ...
(Date:6/16/2015)... -- Fingerprint Cards has received an order of ... portfolio from one of its module partners in ... during the third quarter 2015. The sensors will be used ... Jörgen Lantto, CEO of FPC, comments: " This order ... from smartphone OEMs in integrating touch fingerprint sensors in   ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2
... are old. Really old, in fact, which comes as a ... tree growth in the world's largest tropical region. , Using ... Trumbore, found that up to half of all trees greater ... old. Some of the trees, Trumbore said, are as much ...
... National Human Genome Research Institute (NHGRI), both part ... launched a comprehensive effort to accelerate our understanding ... application of genome analysis technologies, especially large-scale genome ... Atlas (TCGA), will begin with a pilot project ...
... University of Pennsylvania School of Medicine have discovered that ... (pre-mRNA), a process once believed to only take place ... capability in dendrites, the investigators hope to relate this ... dysfunction. Senior author James Eberwine, PhD, Professor of Pharmacology, ...
Cached Biology News:Amazon trees much older than assumed, raising questions on global climate impact of region 2NIH launches comprehensive effort to explore cancer genomics 2NIH launches comprehensive effort to explore cancer genomics 3NIH launches comprehensive effort to explore cancer genomics 4RNA splicing occurs in nerve-cell dendrites 2RNA splicing occurs in nerve-cell dendrites 3
...
EoProbe Eosinophil Staining Kit, 1 Kit...
... kit contains the basic components required for ... natural and recombinant rat L-Selectin in cell ... contains sufficient materials to run ELISAs on ... following conditions are met: The ...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
Biology Products: